The pact adds to a busy run of China deals for Roche and is a bet on medicines that lower visceral fat.
Recap by typeshit. Full story at BioPharma Dive.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
A short local news segment checks the safety concerns around retatrutide, which is still in trials and not approved by the FDA.
Mounjaro held 86.7% of Korea's GLP-1 weight loss market in June, and Hanmi's homegrown Eppe was just approved in five strengths.
Loading…